A 1.7-kb deletion within Pif1.
1695bp deletion that removes the Pif1 helicase domain. Generated by imprecise excision of P{EPgy2}CG3238EY10295.
chromosome | embryonic stage | maternal effect
Pif1167 homozygotes show increased mortality to some chemicals that induce DNA replication stress: moderate sensitivity to hydroxyurea and mild sensitivity to methyl methanesulfonate and bleomycin, but no sensitivity to paraquat, topotecan or nitrogen mustard.
Embryos derived from Pif1167 homozygous mothers rarely hatch and develop more slowly. During early development (1-2h of development at 25[o]C), these embryos show defective nuclear divisions: nuclear fallout (fully prevalent), chromosome clumping (highly prevalent), anaphase bridges and asynchronous divisions. However, there is no statistically significant increase in meiotic defects (i.e. X chromosome nondisjunction).
Pif1167 individuals do not show significant DNA repair defects in P{w[α]} assays: slight decrease in homologous recombination events and unchanged incomplete homologous recombination events that terminate via end joining, as compared to controls.
Brca247, Pif1167 has lethal - all die before end of larval stage phenotype, non-enhanceable by PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-enhanceable by PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-enhanceable by spn-A3
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-enhanceable by spn-A3/PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-enhanceable by mus81Nhe
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-enhanceable by PolD3L2/mus81Nhe
Brca247, Pif1167 has lethal - all die before end of larval stage phenotype, non-suppressible by PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-suppressible by PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-suppressible by spn-A3
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-suppressible by spn-A3/PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-suppressible by mus81Nhe
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype, non-suppressible by PolD3L2/mus81Nhe
Pif1167 is an enhancer of abnormal DNA repair phenotype of PolD3L2
Pif1167/mus81Nhe is a non-enhancer of lethal - all die before end of larval stage phenotype of Brca2KO, PolD3L2
Pif1167/mus81Nhe is a non-suppressor of lethal - all die before end of larval stage phenotype of Brca2KO, PolD3L2
Brca2KO, Pif1167 has lethal - all die before end of larval stage phenotype
Brca247, Pif1167 has lethal - all die before end of larval stage phenotype
Pol32L2, Pif1167 double mutants show more pronounced DNA repair defects in a P{w[α]} assay than Pol32L2 single mutants: more severely decreased homologous recombination events than Pol32L2 and increased incomplete homologous recombination events that terminate via end joining, as compared to wild-type controls.
Pif1167, DNApol-ζ3B individuals do not show significant DNA repair defects in P{w[α]} assays: slight decrease in homologous recombination events and unchanged incomplete homologous recombination events that terminate via end joining, as compared to controls.